Skip to main content
Premium Trial:

Request an Annual Quote

Product Watch: Bio-Rad Inhibitor-Tolerant SYBR Green Supermix

Premium

Bio-Rad this week launched the SsoAdvanced Universal Inhibitor-Tolerant SYBR Green Supermix.

The new master mix is designed to obtain reproducible, optimal-quality qPCR data from the most challenging samples such as crude lysates from plants, tissues, or formalin-fixed paraffin-embedded samples; and other less-than-ideal sources containing PCR inhibitors.

The product has been optimized and validated to tolerate a wider spectrum of PCR inhibitors than other SYBR Green reagents, Bio-Rad said. As with all SSoAdvanced Supermixes, the inhibitor-tolerant version includes Bio-Rad's Sso7d-fusion polymerase. The mix is also compatible with all real-time PCR instruments and functions under any reaction condition, Bio-Rad said.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.